Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04716010 · ClinicalTrials.gov registry record · NA
Developing and Evaluating Product Messaging
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 4,160
- Enrollment target
NCT04716010 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 4,160 participants.
The verdict
NCT04716010, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,160 participants
- Enrollment target
Study Summary
Purpose: To assess the impact of taxes, warnings, and a combination of taxes and warnings on US adults' decisions to purchase products that contain red meat in an online grocery store. Procedures (methods): Participants will be recruited from Prime Panels (an online panel research company). Following online consent, participants will be assigned to one of four trial arms: 1) Control (no warning and no tax), 2) Warnings (all products that contain red meat have a health warning and environmental warning), 3) Tax (30% tax on products that contain red meat), and 4) Combined warning and tax (all products that contain red meat will have the two warnings and a 30% tax). Then, participant will enter an online grocery store reflecting their assigned arm. The participant will be instructed to complete a shopping task in the online grocery store. After completing the shopping task, participants will be redirected to an online survey and answer a series of questions about the shopping task, labels (excluding tax and control groups), and taxes (excluding warning and control groups). Questions will also include standard demographic and health related variables.
Interventions
- OTHER Control
- OTHER Warning Labels
- OTHER Tax
- OTHER Combined Warning Labels and Tax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,160 participants |
| Start Date | 2021-10-18 |
| Est. Completion | 2021-10-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04716010
The ClinicalTrials.gov registry entry for NCT04716010 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4,160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Control is the first listed.
NCT04716010 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04716010 about?
NCT04716010 is a clinical study titled "Developing and Evaluating Product Messaging". Purpose: To assess the impact of taxes, warnings, and a combination of taxes and warnings on US adults' decisions to purchase products that contain red meat in an online grocery store. Procedures (methods): Participants will be recruited from Prime Panels (an online panel research company). Followi...
What is the current status of trial NCT04716010?
This trial is currently completed. It is a NA study. The enrollment target is 4,160 participants. The study started on 2021-10-18. Estimated completion is 2021-10-28.
What interventions are being tested in trial NCT04716010?
The interventions under investigation include: Control (OTHER), Warning Labels (OTHER), Tax (OTHER), Combined Warning Labels and Tax (OTHER).
Who is sponsoring clinical trial NCT04716010?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.